Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Adenosine A1 receptor agonist NNC-21-0147 is a potent neuroprotectant without CV effects

Aug. 24, 1999

ACS research news: Neurocrine Biosciences presents newest CRF antagonist

Aug. 24, 1999

Org-23366: an atypical antipsychotic potentially superior to clozapine

Aug. 23, 1999

Pfizer investigates ORL1 agonists with analgesic activity in rodent models

Aug. 20, 1999

EUK-134 protects against neuronal damage in seizure model

Aug. 20, 1999

Anesta seeks approval for Actiq in the U.K.

Aug. 20, 1999

Long-term Aricept treatment improves cognitive function, prevents decline in patients with AD

Aug. 20, 1999

FDA approves Organon's short-acting neuromuscular blocker Raplon

Aug. 19, 1999

Merck invention centers on GABA-A receptor ligands for epilepsy, anxiety

Aug. 19, 1999

Shionogi synthesizes potent 5-HT7 receptor ligands for CNS, CV disorders

Aug. 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...